Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A 2025 pilot study examined intravenous BPC-157 infusion in two healthy adults receiving doses up to 20 mg
Medical history and medication review to flag any interactions or contraindications before prescribing Goal-specific protocol selection based on injury location, duration, and severity rather than a one-size-fits-all 500 mcg recommendation Written reconstitution and injection instructions with the exact mL and unit markings for the patients specific vial and prescribed dose Injection training for self-administration patients, either in-clinic or via telehealth video walkthrough Week-four check-in to assess response, adjust dose or frequency if needed, and confirm the patient is completing the cycle correctly Pharmacy-grade 503A product with verified purity, sterility, and potency from an FDA-registered compounding pharmacy For patients who have never injected a peptide before, we also review the BPC-157 benefits and mechanism in detail before starting the protocol so the patient understands what the peptide does, what to expect during the cycle, and what results realistically look like at four, eight, and twelve weeks
Someone reads about vitamin shots for energy, sees B12 lipotropic injections marketed as a fat solution, hears about NAD for energy, then wonders how any of it connects to a GLP-1 medication
Answer: Dihexa is a synthetic research peptide, sometimes called a peptidomimetic, studied for its ability to activate hepatocyte growth factor (HGF) receptors in the brain, a pathway tied to the growth of neurons and synaptic connections
Its presence within the combination contributes additional scientific value for investigators interested in evaluating peptide interactions within complex biological systems
